A Study to Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian Federation

Clinical trial NCT04138199 · TERMINATED

Trial details

NCT number: NCT04138199
Sponsor: AbbVie
Status: TERMINATED
Study type: OBSERVATIONAL

HIV-1 Infection

Start date: 2019-11-01
Primary completion: 2020-07-08
Enrollment: 239

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.